
Deep Genomics is an AI-first TechBio organization pioneering a new path for genomic R&D with its AI foundation model platform. They aim to program therapies for any gene and any genetic condition by untangling the complexity in RNA biology, identifying novel targets, and evaluating thousands of possibilities to identify the best therapeutic candidates. Their proprietary AI Platform is designed for data-driven prediction, positive feedback loops, and exponential growth, with their foundation model for RNA Biology, BigRNA, released in 2023 and BigRNA+ currently in development. The company has a diverse team of over 100 members with expertise across AI, genomics, drug development, and related fields, and operates from offices in Toronto, Canada, and Boston, USA.

Deep Genomics is an AI-first TechBio organization pioneering a new path for genomic R&D with its AI foundation model platform. They aim to program therapies for any gene and any genetic condition by untangling the complexity in RNA biology, identifying novel targets, and evaluating thousands of possibilities to identify the best therapeutic candidates. Their proprietary AI Platform is designed for data-driven prediction, positive feedback loops, and exponential growth, with their foundation model for RNA Biology, BigRNA, released in 2023 and BigRNA+ currently in development. The company has a diverse team of over 100 members with expertise across AI, genomics, drug development, and related fields, and operates from offices in Toronto, Canada, and Boston, USA.
About Us Deep Genomics is at the forefront of using artificial intelligence to transform drug discovery. Our cutting-edge AI platform decodes the complexity of RNA biology to identify novel drug targets, mechanisms, and therapeutics inaccessible through traditional methods. With expertise spanning machine learning, bioinformatics, data science, engineering, and drug development, our multidisciplinary team in Toronto and Cambridge, MA is revolutionizing how new medicines are created.
About The Role We’re looking for a highly motivated software engineering intern to be part of our team. You’d work alongside experienced software engineers to build tools and services for our AI-based drug discovery platform. These include building internal web applications and software solutions to make our data and AI easily discoverable, accessible, interpretable and maximally effective for everyone in the R&D organization.
This platform uses TypeScript and React (including Redux Toolkit and MaterialUI) on the front end, Python on the back end, and GCP as our cloud provider. While the position will focus on front-end development, we expect the successful candidate to be involved in all layers of the application.
Basic Qualifications
Deep Genomics thanks all applicants, however only those selected for an interview will be contacted. Deep Genomics welcomes and encourages applications from people with disabilities. Accommodations are available on request for candidates taking part in all aspects of the selection process.
We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.